Bonggo, Rhea Mae .
HRN: 05-67-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
CEFUROXIME 500MG (TAB)
01/25/2024
02/01/2024
PO
500mg
BID
NSVD WITH 2nd Degree RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes